Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Study shows 6 years of adjuvant imatinib significantly reduces relapse risk in high-risk GIST patients.
Adding durvalumab and bevacizumab to TACE improves progression-free survival in hepatocellular carcinoma.